1Silva J,Canter CE.Current management of pediatric dilated cardiomyopathy.Curr Opin Cardiol,2010,25:80-87.
2Morimoto S,Shimizu K,Yamada K,et al.Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy?Am Heart J,1999,138(3 Pt 1):456-459.
3Bristow MR.Beta-adrenergic receptor blockade in chronic heart failure.Circulation,2000,101:558-569.
4Takemoto Y,Hozumi T,Sugioka K,et al.Beta-Blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex.J Am Coll Cardiol,2007,49:778-783.
5Shaddy RE,Tani LY,Gidding SS,et al.Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children:a multi-institutional experience.J Heart Lung Transplant,1999,18:269-274.
6Bruns LA,Chrisant MK,Lamour JM,et al.Carvedilol as therapy in pediatric heart failure:an initial multicenter experience.J Pediatr,2001,138:505-511.
7Askari H,Semizel E,Bostan OM,et al.Carvedilol therapy in pediatric patients with dilated cardiomyopathy.Turk J Peditr,2009,51:22-27.
8Banerjee A,Talreja A,Sonnenblick EH,et al.Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.Mt Sinai J Med,2003,70:225-231.
9Majumdar SR,McAlister FA,Cree M,et al.Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS)study.Clin Ther,2004,26:694-703.
10Turanlahti M,Mildr L,Dellota K,et al.Initial experience of levosimendan in pediatric patients.Pediatr Cardiol,2004,25:603.
5Betti I,Castelli G,Barchielli A.The role of N-terminal PRObrain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure.The PROBE-HF study[J].J Card Fail,2009,15(5):377-384.
6Monteiro S,Franco F,Costa S,et al.Prognostic value of CA125 in advanced heart failure patients[J].Int J Cardiol,2010,140(1):115-118.
7Vizzardi E,Nodari S,D'Aloia A,et al.CA125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure[J].Echocardiography,2008,25(9):955-960.
8Michels VV, Driscoll DJ, Miller FA,et aLProgression of fa- milial and non-familial dilated cardiomyopathy :long term follow up[J].Heart, 2003,89(7) :757-761.
9Gorozhanskaia EG, Sviridova SP, Dobrovol'skaia MM,et al. Selenium and oxidative stress in cancer patients[J].Biomed Khim,2013,59(5) :550-562.
10Beck MA.Antioxidants and viral infections :host immune response and viral pathogenicity[J].J Am Coil Nutr,2001, 20(5 Suppl) :384S-388S.
